1 Min Read
* BIOVERATIV INC - U.S. FDA HAS APPROVED UPDATED LABELING FOR ALPROLIX
* BIOVERATIV INC SAYS LABEL UPDATE INCLUDES ADDITION OF PEDIATRIC DATA RELATED TO PROPHYLACTIC TREATMENT WITH ALPROLIX Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.